Perrigo, Ther-Rx announce availability of Gynazole-1
ST. LOUIS — Perrigo and a subsidiary of K-V Pharmaceutical Co. have launched a new drug for yeast infections in women, the two companies said.
Perrigo and Ther-Rx Corp. announced the availability of Gynazole-1 (butoconazole nitrate vaginal cream) in the 2% strength for treating yeast infections in nonpregnant women.
Ther-Rx has a partnership with Perrigo to manufacture the drug.
"We are pleased to be able to once again offer Gynazole-1 to prescribing healthcare providers and to patients in need of therapy," K-V CEO and Ther-Rx president Greg Divis said. "The availability of Gynazole-1 represents a positive step forward for the company as we continue to provide quality, patient-friendly products to support the health of women across the stages of their lives."
It’s official: Watson changes name to Actavis
PARSIPPANY, N.J. — Watson Pharmaceuticals has formally changed its name to Actavis and changed its New York Stock Exchange ticker symbol to ACT, the company said Thursday.
The generic drug maker, now the world’s third largest, announced its plan to change the name last year after it acquired Actavis. The combined company expects combined 2012 sales to exceed $8 billion.
"Today marks an historic day for Actavis and a milestone in our evolution into a global pharmaceutical leader," Actavis president and CEO Paul Bisaro said. "While we have been operating as one company since last year, today we unite all of our 17,000 employees under a single name, trademarked and protected around the world."
The company has started a multi-year rebranding campaign in which it will change its website, factories, operations and commercial presence around the world and plans to ring the closing bell Thursday at the New York Stock Exchange.
No comments found
Pharmacy retailers, one PBM dominated prescription drug revenues last year, study finds
PHILADELPHIA — Five pharmacies dominated prescription drug dispensing revenues in the United States last year, according to a new study.
The proprietary study, by the Drug Channels Institute, found that pharmacy retailers CVS Caremark, Walgreens, Rite Aid, Walmart and pharmacy benefit manager Express Scripts accounted for 63% of all prescription drug revenues in the $276.5 billion U.S. pharmacy industry in 2012.
"Next year, these companies will benefit from healthcare reform’s implementation, which will sharply increase U.S. spending on prescription drugs," Drug Channels Institute CEO Adam Fein said.
No comments found